Current approach to relapsed acute lymphoblastic leukemia in children

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 3

Peer-Review Report of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Hematology

ISSN

2218-6204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Hematol. Aug 6, 2014; 3(3): 49-70
Published online Aug 6, 2014. doi: 10.5315/wjh.v3.i3.49

Table 6 Children oncology group approach to relapsed acute lymphoblastic leukaemia[29]

Relapse	Site	Time		MRD
B-lineage	Marrow	Early	Chemotherapy vs chemotherapy plus novel agents	Negative	SCT
				Positive	Bridging study before HSCT
		Late	Chemotherapy vs chemotherapy plus novel agents	Negative	Continuation therapy
				Positive	SCT
	IEM	Early	Chemotherapy vs chemotherapy plus novel agents	Any	SCT
				Any	SCT
		Late	Chemotherapy vs chemotherapy plus novel agents	Negative	Continuation therapy
				Positive	SCT
T-lineage	Marrow	Early	Chemotherapy vs chemotherapy plus novel agents	Negative	SCT
		Late		Positive	Bridging study before HSCT
	IEM	Early	Chemotherapy vs chemotherapy plus novel agents
		Late		Any	SCT

IEM: Isolated extramedullary; SCT: Hematopoietic stem cell transplantation.

Citation: Fuster JL. Current approach to relapsed acute lymphoblastic leukemia in children. World J Hematol 2014; 3(3): 49-70
URL: https://www.wjgnet.com/2218-6204/full/v3/i3/49.htm
DOI: https://dx.doi.org/10.5315/wjh.v3.i3.49

Fuster JL. Current approach to relapsed acute lymphoblastic leukemia in children. World J Hematol 2014; 3(3): 49-70 [DOI: 10.5315/wjh.v3.i3.49]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.